David Brochu is the Chief Technical Officer at Autolus and has led the transition of the Company’s manufacturing organization to deliver products for late-stage clinical studies and commercial sale. He joined Autolus from Kedrion USA, where he was the vice president of technical operations and program head for Kedrion SpA’s next generation IVIG development and industrialization effort. In this role David also established various operational functions for the company, including manufacturing, supply chain, engineering, quality, regulatory, program management, and development. Prior to this, he was the vice president of plasma collection operations for Talecris Biotherapeutics (formerly Bayer HealthCare LLC), where he led the operations buildout in the Western United States. Earlier in his career, David headed process development and technology at Talecris leading the preparation and implementation of the technology, process development, and facilities investment strategy for the plasma products business. In this role he led teams of scientists, engineers, and technicians in the development of new protein therapeutics from research to commercial launch. Prior to Talecris, he held engineering and technical operations leadership roles at Bayer and Warner Lambert in the US, EU, and South America. David has over 30 years of operational and development experience. He received a B.S. in chemical engineering from Northeastern University.